http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2399591-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 |
filingDate | 2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2399591-A1 |
titleOfInvention | Semuloparin for the extended prevention of a mortality and/or morbidity event in a patient having undergone hip fracture surgery |
abstract | The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof for the extended prevention of a mortality and/or morbidity event, more specifically venous thromboembolism and death, in a patient having undergone hip fracture surgery. |
priorityDate | 2010-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 56.